Cases of lupus can be traced all the way back to Hippocrates' time in 460-375 BC. However, the systemic form of lupus wouldn’t be formally established until 1904 after extensive work from Jadassohn and Sir William Osler:
• Jadassohn published extensive reviews of Discoid and Systemic Lupus Erythematosus (SLE), highlighting the clinical features and pathologic findings.
• Osler published an astounding 29 cases of “erythema group of diseases,” and though only two in those cases genuinely described SLE, he still contributed to the medical field’s greater understanding of how skin diseases could be accompanied by various systemic manifestations.
Both Jadassohn and Sir William Osler would lay the groundwork for future immunology breakthroughs by understanding lupus as more than just a skin affliction. Breakthroughs such as:
• The discovery of the LE cell by Hargraves and Colleagues in 1948: Hargraves observed a phagocytic phenomenon in the bone marrow of lupus patients in which white blood cells called neutrophils would consume the nuclear material released from the abundance of cells that died from lupus autoantibodies. These cells were termed lupus erythematosus cells or simply LE cells. The presence of LE cells was subsequently considered a biomark of lupus, trailblazing a way for the future application of immunology to lupus studies and the more efficient diagnosing of milder forms of lupus. Testing for LE cells is still factored into lupus diagnosis today, though its become somewhat obsolete due to modern methods of diagnosis.
• The discovery of lupus-related autoantibodies throughout the 1950s: Syphilis testing done by Moore would find that lupus patients produced specific autoantibodies that would mistakenly flag them as positive during testing. In fact, he found that 7% of the 148 individuals who had chronic false-positive syphilis tests had developed systemic lupus, and 30% had symptoms consistent with collagen disease, where those autoantibodies were still produced. Furthermore, Friou would apply a microscopy technique called immunofluorescence to demonstrate the presence of antinuclear antibodies—autoantibodies that specifically target the cell’s nucleus—in lupus patients’ blood. Both these studies would be revolutionary in tracing the development of SLE and its treatments.